| 0 | 💬 0 |
ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2.
(academic.oup.com)
|
Journal of Immunology 2026-08-04 | #covid-19 #antibody #immunotherapy #therapeutics #viral evolution | |
| 0 | 💬 0 |
The conserved bridging domain on HCV E1E2 glycoprotein complex is targeted by neutralizing antibodies from diverse lineages.
(linkinghub.elsevier.com)
|
Cell Reports 2026-08-04 | #neutralization #hepatitis #vaccination #antibody #immunology |